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Babesia bovis is an apicomplexan tick-transmitted pathogen of cattle imposing a global risk and severe constraints to
livestock health and economic development. The complete genome sequence was undertaken to facilitate vaccine
antigen discovery, and to allow for comparative analysis with the related apicomplexan hemoprotozoa Theileria parva
and Plasmodium falciparum. At 8.2 Mbp, the B. bovis genome is similar in size to that of Theileria spp. Structural
features of the B. bovis and T. parva genomes are remarkably similar, and extensive synteny is present despite several
chromosomal rearrangements. In contrast, B. bovis and P. falciparum, which have similar clinical and pathological
features, have major differences in genome size, chromosome number, and gene complement. Chromosomal synteny
with P. falciparum is limited to microregions. The B. bovis genome sequence has allowed wide scale analyses of the
polymorphic variant erythrocyte surface antigen protein (ves1 gene) family that, similar to the P. falciparum var genes,
is postulated to play a role in cytoadhesion, sequestration, and immune evasion. The ;150 ves1 genes are found in
clusters that are distributed throughout each chromosome, with an increased concentration adjacent to a physical gap
on chromosome 1 that contains multiple ves1-like sequences. ves1 clusters are frequently linked to a novel family of
variant genes termed smorfs that may themselves contribute to immune evasion, may play a role in variant erythrocyte
surface antigen protein biology, or both. Initial expression analysis of ves1 and smorf genes indicates coincident
transcription of multiple variants. B. bovis displays a limited metabolic potential, with numerous missing pathways,
including two pathways previously described for the P. falciparum apicoplast. This reduced metabolic potential is
reflected in the B. bovis apicoplast, which appears to have fewer nuclear genes targeted to it than other apicoplast
containing organisms. Finally, comparative analyses have identified several novel vaccine candidates including a
positional homolog of p67 and SPAG-1, Theileria sporozoite antigens targeted for vaccine development. The genome
sequence provides a greater understanding of B. bovis metabolism and potential avenues for drug therapies and
vaccine development.
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Introduction
Babesiosis is a tick-borne, hemoprotozoan disease enzootic
in ruminants in most sub-temperate and tropical areas of the
world (reviewed in [1]). It is recognized as an emerging
zoonotic disease of humans, particularly in immunocompro-
mised individuals [2], and is of historical signiﬁcance as the
ﬁrst protozoan agent recognized to be arthropod transmitted
[3]. With no widely available vaccine and a nearly global
distribution, babesiosis is one of the most important
arthropod-transmitted diseases of cattle, with over half of
the world’s cattle population at risk [4]. Live attenuated
vaccines are used for the control of babesiosis in many parts
of the world, but rely on region-speciﬁc attenuated strains for
which vaccine breakthrough is not uncommon (reviewed in
[5]). Due to the blood-based production of these attenuated
vaccines and the possibility of reversion to virulence with tick
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a disease outbreak in a naı ¨ve cattle population with no
available vaccine would be catastrophic.
Babesia, the causative agent of babesiosis, is in the order
Piroplasmida within the phylum Apicomplexa [6]. Similar to
other members of this phylum, such as the phylogenetically
closely positioned Theileria and its distant cousin, Plasmodium,
Babesia undergoes a complex life cycle that involves both
vector and mammalian hosts. In contrast to Plasmodium, for
which Anopheles mosquitoes vector transmission, Theileria and
Babesia are transmitted via tick vectors. For all three
hemoprotozoans, sporozoites are injected into the blood
stream of the mammalian host and it is at this stage where the
life cycle of Babesia differs from that of Theileria and
Plasmodium. For Theileria, infection leads ﬁrst to lymphocytic
stages followed after schizogony by intraerythrocytic develop-
ment [7]. In plasmodial infection, the sporozoite ﬁrst infects
hepatocytes in which the stage infecting the erythrocytes is
produced. In contrast, babesial infection with sporozoites
leads directly to infection of erythrocytes. Once inside an
erythrocyte, both Theileria and Babesia are found in the
cytoplasm while Plasmodium resides in a parasitophorous
vacuole. In spite of the differences in the mammalian cell
types that the parasites invade, the hallmarks of a B. bovis–
induced clinical syndrome in cattle, including severe anemia,
capillary sequestration of infected erythrocytes, abortion, and
a neurologic syndrome, are remarkably similar to human
malaria caused by Plasmodium falciparum [8,9]. Whether the
mechanisms leading to these clinical features are unique or
are shared between these two related hemoprotozoans is
unknown.
Complete apicomplexan genome sequences for T. parva, T.
annulata, and P. falciparum have been reported [7,10,11].
Comparisons of these genomes revealed that only approx-
imately 30%–38% of the predicted proteins could be
assigned a function, suggesting that the majority of the
proteins for these organisms are novel [10,11]. Data from the
genome sequences demonstrate many differences between
Plasmodium and Theileria, such as the number of rRNA units
and their developmental regulation, the lack of key enzymes
in certain metabolic pathways, lengths of intergenic regions,
gene density, and intron distribution. The genome sequence
of the virulent, tick-transmissible Texas T2Bo isolate of B.
bovis, reported here, will allow for an even more compre-
hensive, genome-wide comparison of this triad of important
vector-borne apicomplexan hemoprotozoa, and can be used
to identify genes that play common and species-speciﬁc roles
in apicomplexan biology. Furthermore, insight from such
comparisons may improve our ability to design potential
prophylactic and therapeutic drug targets.
Results/Discussion
Genome Structure and Sequence
Assembly of whole genome shotgun sequence data of the
Texas T2Bo isolate of B. bovis indicates that the parasite
contains four chromosomes, conﬁrming previous results
from pulse ﬁeld gel electrophoresis [12,13]. Chromosome 1,
the smallest of the four chromosomes, contains a large
physical gap ﬂanked by two large contigs (821,816 bp and
285,379 bp in length). The gap is estimated to be 150 kbp by
pulse ﬁeld gel electrophoresis (unpublished data) and con-
tains ﬁve contigs that vary in size from 12 kbp to 28 kbp, with
the order of the contigs in the gap unknown. Chromosomes 2
and 3 were fully sequenced and are 1,729,419 and 2,593,321
bp in length, respectively. Chromosome 4 contains an
assembly gap that has not been unambiguously resolved; a
1,149 bp contig separates two contigs of 827,912 bp and
1,794,700 bp. Thus, the nuclear genome of B. bovis consists of
four chromosomes of 2.62, 2.59, 1.73, and ;1.25 Mbp in
length. At 8.2 Mbp in size, the genome of B. bovis is similar in
size to that of T. parva (8.3 Mbp) [10] and T. annulata (8.35
Mbp) [7], the smallest apicomplexan genomes sequenced to
date (Table 1).
Each B. bovis chromosome contains an AþT-rich region ;3
kbp in length presumed to be the centromere (Figure 1) based
on features similar to those described for the putative
centromere on P. falciparum chromosome 3 [14]. Three of
the chromosomes are acrocentric, while chromosome 4 is
submetacentric. The organization of telomeres and sub-
telomeric regions resembles that seen in Theileria [7,10], as
protein coding genes are found within 2–3 kbp of the end of
CCCTA3–4 telomeric repeat sequences. The B. bovis genome
contains three rRNA operons, two on chromosome 3 and one
on chromosome 4, and 44 tRNA genes distributed across all
four chromosomes. A total of 3,671 nuclear protein coding
genes are predicted in the B. bovis assembled sequence data.
In addition to the nuclear genome, the parasite contains two
AþT-rich extra-chromosomal genomes: a circular 33 kbp
apicoplast genome and a linear ;6 kbp mitochondrial
genome (Table 1), described below.
Metabolic Potential and Membrane Transporters
A series of in silico metabolic pathways for B. bovis were
reconstructed from 248 proteins assigned an EC number,
including glycolysis, the tricarboxylic acid cycle and oxidative
phosphorylation, de novo pyrimidine biosynthesis, glyceroli-
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Author Summary
Vector-transmitted blood parasites cause some of the most widely
distributed, serious, and poorly controlled diseases globally, includ-
ing the most severe form of human malaria caused by Plasmodium
falciparum. In livestock, tick-transmitted blood parasites include the
protozoa Theileria parva, the cause of East Coast fever and Babesia
bovis, the cause of tick fever, to which well over half of the world’s
cattle population are at risk. There is a critical need to better
understand the mechanisms by which these parasites are trans-
mitted, persist, and cause disease in order to optimize methods for
control, including development of vaccines. This manuscript
presents the genome sequence of B. bovis, and provides a whole
genome comparative analysis with P. falciparum and T. parva.
Genome-wide characterization of the B. bovis antigenically variable
ves1 family reveals interesting differences in organization and
expression from the related P. falciparum var genes. The second
largest gene family (smorf)i nB. bovis was newly discovered and may
itself be involved in persistence, highlighting the utility of this
approach in gene discovery. Organization and structure of the B.
bovis genome is most similar to that of Theileria, and despite
common features in clinical outcome is limited to microregional
similarity with P. falciparum. Comparative gene analysis identifies
several previously unknown proteins as homologs of vaccine
candidates in one or more of these parasites, and candidate genes
whose expression might account for unique properties such as the
ability of Theileria to reversibly transform leukocytes.pid and glycerophospholipid metabolism, the pentose phos-
phate pathway, and nucleotide interconversion (Figure 2).
Notably, a number of major pathways appear to be lacking in
the parasite, including gluconeogenesis, shikimic acid syn-
thesis, fatty acid oxidation, the urea cycle, purine base salvage
and folate, polyamine, type II fatty acid, and de novo purine,
heme, and amino acid biosyntheses. Although heme biosyn-
thesis activity present in P. falciparum is predicted to be absent
in B. bovis, it does encode delta-aminolevulinic acid dehy-
dratase (BBOV_II001120), which catalyzes the second step in
heme biosynthesis.
The predicted metabolic proﬁle of B. bovis is more similar
to that of Theileria [7,10] than to that of P. falciparum [11]. Like
Theileria, B. bovis does not appear to encode pyruvate
dehydrogenase. Thus, there is no classical link between
glycolysis and the tricarboxylic acid cycle. Interestingly,
massively parallel signature sequencing has demonstrated
that lactate dehydrogenase is the third most highly tran-
scribed gene in T. parva schizonts [15], suggesting that in these
organisms lactate may be the primary end product of
glycolysis. This could be true for B. bovis as well. The enzymes
adenine phosphoribosyltransferase and hypoxanthine-gua-
nine phosphoribosyl-transferase (HGPRT) involved in salvage
of purine bases appear to be lacking in B. bovis. HGPRT is
present in P. falciparum (PF10_0121) [11], but absent from T.
parva and T. annulata. Interestingly, although the purine
salvage pathway is incomplete, B. bovis may be able to salvage
purine nucleosides [16]. A recent analysis of B. bovis expressed
sequence tags (ESTs) identiﬁed two adenosine kinases [17], a
ﬁnding corroborated by the genome sequence data, which
also revealed the presence of adenosine deaminase. These
enzymes are absent in T. parva, while P. falciparum encodes
adenosine deaminase. While we cannot exclude that HGPRT
is present in the chromosome 1 gap, the apparent absence of
HGPRT in B. bovis is in contrast to previous studies
demonstrating the incorporation of radio-labeled hypoxan-
thine in parasite erythrocyte cultures [16,18]. Although
several enzymes involved in purine salvage are present, there
appears to be no direct path to the production of inosine
monophosphate, and it is possible that the necessary enzymes
are present but are not similar to known enzymes. Unlike P.
falciparum and the Theileria spp., B. bovis does not appear to
encode dihydrofolate synthase, which converts dihydropter-
oate to dihydrofolate. However, this deﬁciency could be
compensated through importation via a folate/biopterin
transporter (BBOV_IV002460) and increased dihydrofolate
reductase–thymidylate synthase (DHFR-TS) activity. Consis-
tent with a previous study using the Israel strain of B. bovis
[19], the T2Bo DHFR-TS contains three of the four amino
acid substitutions found in a mutant P. falciparum DHFR-TS
with strong resistance to pyrimethamine, a DHFR inhibitor.
An additional single point mutation is linked with the ability
of B. bovis to develop strong resistance to pyrimethamine [19].
Babesia bovis has the smallest number of predicted mem-
brane transporters [20] among the sequenced apicomplexan
species (Table S1), but encodes more members of some
families (for example, glucose-6-phosphate/phosphate and
phosphate/phosphoenolpyruvate translocators, members of
the drug/metabolite transporter superfamily). It encodes
fewer members of the ABC efﬂux protein family than T.
parva but has more transporters for inorganic cations,
including a cation diffusion facilitator family protein that is
absent in T. parva and other apicomplexans. Both B. bovis and
T. parva lack aquaporins, the calcium:cation antiporters, and
amino acid permeases that are present in the genome of P.
falciparum. Orthologs of the different types of amino acid
transporters cannot be identiﬁed in B. bovis, including the
dicarboxylate/amino acid:cation (Na
þor H
þ) symporter family
amino acid:cation symporter that is present in T. parva [10].
The Apicoplast
Most members of the phylum Apicomplexa harbor a semi-
autonomous plastid-like organelle termed the apicoplast,
which was derived via a secondary endosymbiotic event [21].
The B. bovis apicoplast genome is 33 kbp and unidirectionally
encodes 32 putative protein coding genes, a complete set of
tRNA genes (25), and a small and large subunit rRNA gene
(Figure S1). The B. bovis apicoplast genome displays similar-
ities in size, gene content, and order to those of Eimeria tenella,
P. falciparum, T. parva, and Toxoplasma gondii (Table S2; [22–
24]). As observed with other apicoplast genomes, the B. bovis
apicoplast genome is extremely AþT rich (78.2%), in contrast
to the nuclear genome (58.2%).
In addition to the apicoplast genome encoded proteins, it
has been demonstrated in P. falciparum that proteins encoded
by nuclear genes are imported into the apicoplast (reviewed
in [25]) to carry out a variety of metabolic processes,
including heme biosynthesis [26], fatty acid biosynthesis
[27], and isoprenoid precursor synthesis via the methylery-
throse phosphate pathway [28]. Nuclear encoded proteins
targeted to the apicoplast of P. falciparum have a bipartite
targeting sequence consisting of a signal peptide that directs
the protein to the secretory pathway and an apicoplast transit
peptide that redirects the protein from the default secretory
pathway into the lumen of the apicoplast [29,30].
Analysis of the metabolic functions ascribed to the
apicoplast in P. falciparum reveals that only the enzymes for
isoprenoid biosynthesis are found in B. bovis. To detect
additional apicoplast-targeted proteins, PlasmoAP, a pro-
gram developed to predict apicoplast targeting for P.
Table 1. Genome Characteristics of B. bovis, T. parva, and P.
falciparum
Features Species
P. falciparum T. parva B. bovis
Size (Mbp) 22.8 8.3 8.2
Number of chromosomes 14 4 4
Total GþC composition (%) 19.4 34.1 41.8
Size of apicoplast genome (kbp) 35 39.5 33
Size of mitochondrial genome (kbp) ;6 linear ;6 linear ;6 linear
Number of nuclear protein coding genes 5,268 4,035 3,671
Average protein coding gene length (bp)
a 2,283 1,407 1,514
Percent genes with introns 53.9 73.6 61.5
Mean length of intergenic region (bp) 1,694 405 589
GþC composition of intergenic region 13.8 26.2 37
GþC composition of exons (%) 23.7 37.6 44
GþC composition of introns (%) 13.6 25.4 35.9
Percent coding 52.6 68.4 70.2
Gene density
b 4,338 2,057 2,228
aNot including introns.
bGenome size/number of protein coding genes.
doi:10.1371/journal.ppat.0030148.t001
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B. bovis Genome Sequencefalciparum [31], was used and revealed only 14 additional
candidate proteins. This result is, perhaps, not unexpected, as
the program was trained with P. falciparum sequences and
likely works well only for P. falciparum because of skewed
codon usage resulting from the low GþC content of P.
falciparum. A third approach included visual inspection of
BLAST search outputs of the entire B. bovis proteome against
the nr database (National Center for Biotechnology Informa-
tion) for potential amino-terminal extensions. This search
resulted in 25 potential apicoplast-targeted sequences that
had non-apicomplexan homologs with signiﬁcant E values
and bona ﬁde amino terminal extensions. In total, 47 proteins
(the eight involved in the methylerythrose phosphate path-
way, 14 SignalP sequences identiﬁed with PlasmoAP, and 25
proteins identiﬁed through BLAST and visual inspection for
amino terminal extentions) are predicted to be targeted to
the B. bovis apicoplast (Table S3), by far the fewest of any
organism for which this type of analysis has been done. P.
falciparum and T. parva are predicted to have 466 and 345
apicoplast-targeted proteins, respectively [10,32]. The paucity
of proteins predicted to be targeted to the B. bovis apicoplast
may partially reﬂect the biology of the organism, with fewer
functions attributed to the B. bovis apicoplast compared to P.
falciparum, but is more likely a reﬂection of the lack of
appropriate prediction algorithms.
The apicoplast has been an attractive target for develop-
ment of parasiticidal drug therapies as the biosynthetic
pathways represented therein are of cyanobacterial origin
and differ substantially from corresponding pathways in the
mammalian host [21,33]. A recent study of the apicomplexan
T. gondii demonstrated that fatty acid synthesis in the
apicoplast is necessary for apicoplast biogenesis and main-
tenance, and indicates that this pathway would be an ideal
target for drug design [34]. Thus, the reduced metabolic
potential of B. bovis has important ramiﬁcations for drug
design, suggesting that drugs targeting fatty acid synthesis
would not be effective against babesiosis due to the absence
of this pathway.
The Mitochondrion
B. bovis contains a 6 kbp linear mitochondrial genome
(Figure S2). It encodes three putative protein coding genes,
including cytochrome c oxidase subunit I, III, and cyto-
chrome b. These are membrane-bound proteins that form
part of the enzyme complexes involved in the mitochondrial
respiratory chain. Cytochrome b and c subunit III are
encoded on the same strand, while cytochrome c subunit I
is encoded on the opposite strand. This coding arrangement
is identical to that of Theileria spp. but different from that of
P. falciparum [7,11,35]. Each of the encoded proteins employs
the universal ATG as the start codon, in contrast to the T.
parva cytochrome c subunit I, which has an AGT start codon
[35]. In addition to the three protein coding genes, the B. bovis
mitochondrial genome includes at least ﬁve partial rRNA
gene sequences ranging in size from 34 to 301 bp. All ﬁve
rRNA sequences are homologous to parts of the large
ribosomal subunit of rRNA. They are encoded on both
strands of the mitochondrial genome with rRNA 1 and 5 on
the same strand and 2, 3, and 4 on the opposite strand. A
terminal inverted repeat was identiﬁed from position 11–180
and 6005–5836.
Protein Families
The B. bovis proteome was used to construct protein
families using Tribe-MCL, a sequence similarity matrix-based
Markov clustering method, and a method based on a
combination of hidden Markov model domain composition
and sequence similarity [36]. In addition to housekeeping
gene families found in most eukaryotes, the pathogen
contains only two large gene families. One of these families,
encoding the variant erythrocyte surface antigen (VESA), has
been previously deﬁned [37]. The second, which we have
termed SmORF (small open reading frame), is novel. Smaller
notable families encode a 225 kD protein, known as spherical
body protein 2 (SBP2) [38], and the variable merozoite surface
antigen (VMSA) family [39].
VESA1. VESA1 is a large (.300 kD), heterodimeric protein
composed of VESA1a and VESA1b that is synthesized by B.
bovis and subsequently exported to the surface of the host
erythrocyte [40]. VESA1 undergoes rapid antigenic variation
and has been implicated in host immune evasion and
cytoadhesion, both of which would be expected to play a
vital role in persistence and pathogenesis [41,42]. VESA1 is
thought to be the functional homolog of PfEMP1, encoded by
the var gene family, in P. falciparum [43]. The ves1 genes
comprise the largest family in the B. bovis genome. While
sequence identity and the presence of similar secondary
amino acid structures make it clear that these genes belong to
the same family, two distinct types exist (ves1a and ves1b,
encoding VESA1a and VESA1b, respectively) that possess
highly variable regions of sequence composition, length, and
gene architecture (Figure 3). Genomic analysis predicts 119
ves1 genes in the available sequence (72a,4 3 b, and four
unclassiﬁed; Table S4). However, there is a gradient of
increasing concentration of ves1 genes in the sequence
immediately adjacent to the physical gap on chromosome 1,
and the contigs that appear to reside in the gap contain ves1-
like sequences, indicating that additional ves1 genes reside in
the gap. An estimated gap size of 150 kbp would limit the
number of genes within the missing sequence to less than 40,
resulting in a total of approximately 150 ves1 genes, far fewer
than previously predicted [37]. All but three members of the
ves1 family are found in clusters of two or more genes, with
individual clusters separated by a few kilobases to nearly one
megabase. Interestingly, ves1 genes are distributed through-
Figure 1. Representation of B. bovis Centromeres, ves1, and smorf Genes
Each chromosome is represented by a black line, with the chromosome
number shown on the left. Centromeres are depicted as black dots. ves1
loci are depicted as colored boxes, and the number of ves1 and smorf
genes in each locus is shown above or below the colored boxes,
respectively. Red and blue boxes indicate the presence of at least one
ves1a/ves1b or ves1a/ves1a pair, respectively, within the cluster.
doi:10.1371/journal.ppat.0030148.g001
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observation that genes involved in antigenic variation,
immune evasion, and sequestration, including P. falciparum
var genes, are only occasionally found internally and are
predominately telomerically located [11,44]. While ves1 genes
are also found near telomeres and centromeres, 89 genes
(75%) are located distal to these chromosomal structures.
Transcription of ves1 genes has been hypothesized to occur
at a ‘‘locus for active transcription’’ (LAT), described as a
divergently oriented pairing of ves1a and ves1b genes [37].
This large locus encompasses nearly 13 kbp and includes
ves1a and ves1b (each .4 kbp), a short intergenic region
(,500 bp), and short portions of each gene found as blocks of
repeats and motifs downstream from each ves1 coding region.
The genome sequence contains 24 loci (Figure S3) with paired
ves1a/ves1b genes with similar length, structure, and physical
arrangement as found in the published LAT. This head-to-
head arrangement is also found for 18 ves1a genes of similar
length, resulting in nine loci containing ves1a/ves1a paired
genes. These two groups of paired genes account for greater
than half (66/119) of the annotated ves1 genes (Table S4), and
exhibit the highest level of sequence identity and structural
similarity among ves1a and ves1b genes.
The remaining ves1 genes cannot be easily sorted according
to the previously described head-to-head arrangements, and
many of these genes are signiﬁcantly truncated. All of them
can be classiﬁed as either ves1a or ves1b, with the exception of
four ves1 genes located on chromosome 3. It is possible that
the genes not arranged in putative LATs represent ancestral
forms of ves1 and now play the role of functional pseudo-
Figure 2. Comparison of Major Metabolic Pathways in B. bovis, T. parva, and P. falciparum
Solid arrows indicate single step enzymatic reactions, dashed lines indicate multi-step reactions, and dotted lines indicate incomplete or unknown
pathways. Inhibitory drugs are indicated with red arrows. Glucose is assumed to be the major carbon and energy source. Non-functional pathways in P.
falciparum, T. parva, and B. bovis are shown in boxes with a red X. Pathways denoted with blue text are present in P. falciparum, T. parva, and B. bovis.
Pathways denoted with green text are present in P. falciparum and T. parva but not in B. bovis, and pathways denoted with red text are exclusively
found in P. falciparum.
doi:10.1371/journal.ppat.0030148.g002
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a functional LAT to create antigenic variation [45].
ves1a and ves1b exhibit sequence similarity, but have
different gene architecture. ves1a genes that are members
of potential LATs tend to have three exons: two small exons
followed by a large third exon are separated by two short
introns. The ves1b genes show considerably more diversity, as
they have numerous introns that are not consistent in length
or location [37,41]. Even among ves1b genes in potential
LATs, gene length varies from 987 to 3,642 bp, and the
number of introns ranges between 2 and 11.
Although the ves1a and ves1b genes are structurally distinct,
areas of sequence conservation and topological similarities
exist among the predicted polypeptides. The corresponding
conserved stretches of nucleotide identity may be exploited
as recombination sites for the generation of antigenic
diversity, in addition to encoding a functional motif. Because
VESA1 is exported to the surface of infected erythrocytes
[40], it is notable that only seven of the 119 potential products
are predicted to possess an N-terminal signal peptide (which
again suggests that current signal prediction algorithms may
not be suitable for B. bovis). Most predicted VESA1 proteins
have a large extracellular domain followed by a single
transmembrane segment and a short cytoplasmic tail. This
topology is conserved in VESA1a proteins encoded by genes
in ves1a/ves1b and ves1a/ves1a pairings (35/42 ves1a genes), and
to a lesser extent in VESA1b proteins encoded by genes in the
ves1a/ves1b pairings (15/24 ves1b members). As with exon
structure and gene length, however, considerably less
conservation exists among the remaining proteins, as only
21/53 follow this pattern (Table S4).
VESA1a is distinguished from VESA1b by the presence of a
coiled-coil domain located near the center of the predicted
protein, with 83% of all VESA1a subunits and 98% of
VESA1a subunits from potential LATs containing this
domain. Of the 11 VESA1a subunits that do not contain
the coiled-coil domain, eight are encoded by truncated genes
containing less than 312 amino acids and none are encoded
by genes exhibiting the typical three exon structure. In
contrast to VESA1a, only 4/43 VESA1b subunits contain the
coiled-coil domain. An additional characteristic found
almost exclusively among the VESA1a subunits is the
presence of two distinct motifs that are variable among the
predicted protein sequences but contain invariant amino
acids at speciﬁc positions. These domains, referred to as the
variant domain conserved sequences one and two (VDCS-1
and  2) [37], are arranged in tandem and located near the
coiled-coil domain. The T2Bo consensus sequence for VDCS-
1 is K(N,D)x(L,I,V) (S,K)xxIxxxxxx(L,V) and for VDCS-2 is
CxxCxxHxxKCGxxxxxxxCxxCx(Q,N)xxxxGXPS. While VE-
SA1b subunits are essentially devoid of this motif, the VDCS-
1a n d 2 also help to deﬁne the subsets into which the
VESA1a sequences are organized. VESA1a subunits pre-
dicted from the ves1a/ves1b pairs all possess perfect matches
to VDCS-1 and  2 and only four motifs (three VDCS-1 and
one VDCS-2) are missing from those coded by ves1a/ves1a
pairs. In areas where these four missing motifs would
normally be found, a similar amino acid pattern exists that
does not match the motif perfectly. Of the remaining
VESA1a subunits, 16/30 contain VDCS-1 and 17/30 possess
VDCS-2.
Due to their resemblance to the published LAT [37], 33
pairs of ves1 genes should be considered potential tran-
scription sites. The potential LATs are not clustered, and are
distributed throughout the chromosomes. To better under-
stand whether one or more of these potential sites of
transcription were active, we examined T2Bo ves1 gene cDNA
sequences. Primer sets for three different experiments were
designed to target (1) speciﬁc genes, (2) sets of genes, or (3)
the published LAT (Figure 3), and a total of 66 ves1a and 93
ves1b cDNA clones were analyzed. Unexpectedly, these cDNA
represented 50 and 59 unique ves1a or ves1b sequences,
respectively. Equally surprising, only one of the ves1a and
none of the ves1b unique cDNA sequences matched a
genomic ves1a or ves1b sequence. The ves1 cDNAs displayed
up to 50% sequence divergence in pairwise comparisons for
transcripts within a given experiment. In experiment 1
(designed to target speciﬁc genes), 83% of the ves1a had
.91% sequence identity in pairwise comparisons while the
ves1b cDNAs displayed a bimodal distribution, with 46%
having .91% sequence identity and 50% having only 56%–
70% sequence identity. The RNA used for these experiments
was obtained from B. bovis T2Bo culture more than two years
following isolation of the genomic DNA used to construct the
libraries used for sequencing, possibly accounting for some of
the sequence diversity, i.e., due to changes in the population
represented in the culture at the time of sampling. However,
although variation over time may account for some of the
differences between the cDNA and genomic sequences, the
number of unique sequences obtained from a single time
point exceeds the number of predicted expression sites for
ves1 genes. Consistent with this ﬁnding, numerous ves1 genes
were also represented in EST data [17]. Var gene expression,
while ‘‘leaky’’ in the ring stages of P. falciparum, appears to be
restricted to a single, or very few, alleles in individual parasite
populations in vivo [46,47]. However, multiple var transcripts,
although far fewer than for B. bovis, have been detected when
the organism is cultured in vitro [48]. One possible
Figure 3. Diagram of a Locus Containing the ves1a, ves1b, and smorf Genes
The genome backbone is a gray line, ves1a exons are blue, ves1b exons are red, and the SmORF exon is yellow. Introns are shown as blank boxes
through which the genome backbone is seen. The systematic gene name for each gene is shown. Transmembrane helices (black bars), coiled-coil
domains (green boxes), variant domains with conserved sequences 1 and 2 (pink boxes), and the SmORF signal peptide (orange box) are indicated.
Arrows represent the positions of the primers for each of the cDNA experiments. The experiment number is indicated to the right of the primer sets,
with experiment 1 targeting specific genes, experiment 2 sets of genes, and experiment 3 the published LAT.
doi:10.1371/journal.ppat.0030148.g003
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transcripts may be that, similar to the var genes, ves1 genes are
removed from in vivo transcriptional controls and/or
phenotypic selection when the organism is grown in vitro.
While in vivo analysis of ves1 transcription remains to be
performed, the number of diverse transcripts is interesting,
and may suggest more widespread transcription and alter-
native post-transcriptional control mechanisms than ob-
served in other hemoprotozoa.
SmORFs. Found associated with the ves1 genes across all
four chromosomes are members of the second largest protein
family (SmORFs) in the B. bovis genome (Figures 1 and 2).
These ‘‘small open reading frames’’ (so named due to their
association with, but smaller size than the ves1 genes) include
44 genes with lengths ranging from 381 to 1,377 nucleotides
with no signiﬁcant sequence identity to any protein or gene
sequence in available databases. When compared to VESA
proteins, a higher degree of sequence conservation (;50%
amino acid identity for most pairwise comparisons, with a
range from 28%–95%) is found among SmORF paralogs, and
42/44 members consist of a single exon. Additionally, 43
family members are predicted to have a signal peptide, and all
44 are predicted by TMHMM [49] to exist extracellularly.
Alignment of the SmORF sequences reveals four blocks of
conserved sequence interrupted by linking sequence present
in only one or a few of the SmORF paralogs (Figure S4). These
long linking sequences interspersed between the blocks of
identity in a few proteins account for the increased peptide
length for the longer members of the family. Results from
experiments designed to detect smorf transcripts were similar
to that for ves1: two of ﬁve cloned products matched the
predicted genome sequence while the remaining clones
differed. The prevalence of canonical signal peptides among
SmORFs, and their uniform association with ves1 clusters,
tempts speculation that these proteins may play a functional
role in VESA1 biology, or may, themselves, contribute to
antigenic variation and immune evasion, or both. However,
elucidation of the function of these proteins awaits bio-
chemical and immunological analysis.
SBP2 family. The spherical body is an apical organelle
thought to be analogous to dense granules in other
apicomplexan organisms [50]. SBP2 (also known as BvVa1)
is a 225 kD immunostimulatory protein from the spherical
body that is released into the host erythrocyte upon invasion
and localizes to the cytoplasmic side of the erythrocyte
membrane [38,51–53]. The original study noted that there
were multiple copies of the 59 end of the gene, while the 39
end appeared to be single copy [51]. Consistent with this
study, the genome sequence reveals that there are 12
truncated copies of the SBP2 gene corresponding to the 59
end of the full-length gene, and one full-length copy. The full-
length gene and one truncated gene are on chromosome 4,
with all remaining truncated copies on chromosome 3. The
truncated genes on chromosome 3 occur in three clusters of
two, four, and ﬁve genes. The genes occurring in the 2- and 5-
gene clusters are interspersed with another set of highly
conserved (88%–100%) gene repeats (BBOV_III005620,
BBOV_III006470, BBOV_III006490, BBOV_III006510,
and BBOV_III006530) that have no homologs in the public
databases. The 12 truncated SBP2 genes have sequence
identities ranging from 27%–99% in pairwise comparisons,
with the greatest identity in the ﬁrst 30 amino acids. Previous
analysis of EST sequences indicates that more than one of
these truncated genes are transcribed [17].
VMSA. The variable merozoite surface antigen genes
encode a family of immunostimulatory proteins that are a
target of invasion blocking antibodies [39,54,55]. As in related
Mexico strains of B. bovis [56], the T2Bo genome contains ﬁve
vmsa genes, including msa1 and four copies of msa2. The
VMSA genes reside on chromosome 1, with the four msa2
copies arranged tandemly in a head-to-tail fashion, and msa1
residing ;5 kbp upstream from the msa2 genes. Interestingly,
the VMSAs do not have homologs in Theileria spp. or P.
falciparum.
Comparative Analyses of Hemoprotozoan Proteomes
Clusters of orthologous groups. Similarity clustering using
the predicted proteomes of B. bovis, T. parva, and P. falciparum
created 1,945 three-way clusters of orthologous groups
(COGs) (Figure S5; Table S5). As expected from phylogenetic
studies, the B. bovis proteome is more closely related to that of
T. parva. Approximately half of the remaining B. bovis
proteins not included in the three-way COGs fell into two-
way COGs with proteins from T. parva, while B. bovis and P.
falciparum shared only 111 two-way COGs. Remaining after
cluster analysis were 706, 1,107, and 3,309 unique genes for B.
bovis, T. parva, and P. falciparum, respectively (Tables S6–S8).
Since P. falciparum, T. parva, and B. bovis all have complex
life cycles that involve arthropod vector and mammalian host
stages, Jaccard-ﬁltered COG (Jf-COG) data were used to
search for B. bovis orthologs of proteins that have been
characterized in T. parva and P. falciparum as targets of
protective immune responses, as well as those that play a role
in stage-speciﬁc parasite biology. Many genes exclusively
expressed in sexual stages of P. falciparum (for example
PfCDPK3, PfLAMMER, and Pfs230) do not share Jf-COGs
with T. parva or B. bovis, a difference potentially associated
with the different vector (mosquito versus tick) that transmits
Plasmodium. Likewise, P. falciparum sporozoite genes that are
expressed initially in the mosquito, such as Pfs 25/28,
exported protein 2, circumsporozoite protein, circumspor-
ozoite protein/thrombospondin-related anonymous protein-
related protein, and sporozoite microneme protein essential
for cell traversal 1 and 2, also do not cluster with T. parva or B.
bovis proteins. Since B. bovis does not have a pre-erythrocytic
liver stage, as expected, orthologs of P. falciparum liver stage
proteins such as PfLSA 1–3 are not detected. P. falciparum
erythrocytic stage proteins such as the PfMSPs were not
detected in B. bovis, nor were plasmodial rhoptry and rhoptry-
associated proteins (RAPs). However, BbRAP-1a (BBO-
V_IV009860 and BBOV_IV009870) forms a Jf-COG with
its T. parva (TP01_0701) and T. annulata (TA05760) orthologs.
Interestingly, B. bovis encodes a protein (RRA; BBO-
V_IV010280) most similar to RAP-1b, previously described
only in B. bigemina [57].
Noteworthy P. falciparum genes that have Jf-COGs with B.
bovis are thrombospondin-related anonymous protein
(TRAP), p36 protein, Pf12, Sir2, PfATP6, and P0. PfTRAP is
expressed exclusively in sporozoites, while BbTRAP is ex-
pressed in both sporozoite and blood stages [58]. A
plasmodial surface membrane protein, p36 is a member of
the p45/48 sporozoite protein family. It participates in liver
stage parasite development, and immunization with Pfp36
knockout parasites results in protective immunity against
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p36 as a potential knockout gene for development of
attenuated vaccines [59]. Pf12 is a merozoite surface protein
that is recognized strongly by antibodies of naturally infected
individuals [60]. An ortholog of the Sir2 protein, involved in
P. falciparum var gene silencing [61], is present in B. bovis
(BBOV_I003070), forming a Jf-COG with orthologs in P.
falciparum (PF13_0152), T. parva (TP01_0527), and Crypto-
sporidium parvum (cgd7_2030), but is apparently absent from
T. annulata. An ortholog of PfATP6, the gene thought to be
the target of the drug artemisinin used to treat drug-resistant
malaria, is found in B. bovis (BBOV_II005700) [62]. Finally,
BBOV_IV004540 forms a Jf-COG with P0 from P. falciparum
(PF11_0313), T. parva (TP01_0294), and T. annulata
(TA21355). P0 is a ribosomal phosphoprotein with immuno-
protective properties [63].
Immunostimulatory proteins that form Jf-COGs with B.
bovis include a T. parva protein annotated as polymorphic
immunodominant protein (PIM) (TP04_0051). This poly-
morphic immunodominant protein is the target of sporozoite
neutralizing antibodies [64], and falls into a Jf-COG with B.
bovis protein BBOV_II005100, T. annulata protein TA17315,
known as TaSP [65], and P. falciparum protein PF14_0369.
However, the orthologs are half the length of the T. parva
protein and do not contain a Q/E-rich central repeat domain
that is characteristic of PIM. Of six additional antigens from
T. parva (TP01_0056, TP02_0849, TP02_0767, TP02_0244,
TP02_0140, TP03_0210) that are the targets of parasite-
speciﬁc bovine MHC class I–restricted CD8
þ cytotoxic T cells
[66], four have orthologs in B. bovis (BBOV_IV000410,
BBOV_IV006970, BBOV_III011550, BBOV_III004230,
BBOV_III010070) and P. falciparum (PFC0350c, PF13_0125,
MAL7P1.14, PF11_0447, PF14_0417, PF07_0029). BBO-
V_IV000410, one of the genes not found in P. falciparum,
encodes a signal peptide-containing protein whose T.
annulata homolog is targeted to the membrane [67]. B. bovis
ACS-1 (BBOV_III010400) has been shown to stimulate CD4
þ
T lymphocyte responses in immune cattle [68], and forms a Jf-
COG with T. parva (TP02_0107) and P. falciparum (PFL1880w)
proteins. The B. bovis apical membrane antigen 1 (AMA-1;
BBOV_IV011230) [69] is a micronemal protein that forms a
Jf-COG with P. falciparum (PF11_0344), T. parva
(TP01_0650), and T. annulata (TA02980) and has additional
homologs with other apicomplexans. The B. bovis AMA-1 gene
is located on chromosome 4 and is part of a syntenic cluster
of four genes present across the P. falciparum, T. parva, and T.
annulata genomes.
A unique aspect of T. parva and T. annulata is the ability of
the schizont stage of these parasites to transform the
leukocytes they reside in to a cancer-like phenotype [70].
This reversible change is dependent on the presence of viable
parasites. Although a number of Theileria molecules that
could interfere with host cell signaling pathways controlling
cell proliferation and apoptosis have been mined from the
genome sequence of both pathogens, no single molecule in
either parasite could be linked with the phenotype. In
general, both parasites encode the same repertoire of
candidate proteins, suggesting that subtle differences account
for the observation that T. parva transforms T and B cells
while T. annulata transforms B cells and macrophages. As
anticipated, the expansion in the number of genes coding for
choline kinase in T. parva and T. annulata, which may
contribute to increased lipid metabolism in transformed
cells, is not present in B. bovis, which encodes a single copy of
this gene. In an effort to further reﬁne a list of candidate
transformation-associated genes for T. parva, we analyzed a
list of 1,107 T. parva proteins that do not fall into a Jf-COG
with proteins from P. falciparum or B. bovis (Table S7). There
are 262 proteins predicted to contain a signal peptide or
signal anchor and are not predicted to be targeted to the
apicoplast. Cross-referencing this list with transcriptional
data derived from oligonucleotide based microarrays com-
paring T. parva schizonts and sporozoites reveals that 35 genes
in the list are highly expressed in schizonts. These include two
members of the TashAT gene family previously implicated in
T. annulata transformation [71], and one member of a
telomeric gene family [7]. It is notable that the remaining
genes are all annotated as hypothetical proteins, emphasizing
the need for a concerted effort to study the role of these
novel proteins.
Syntenic analyses. It is possible that due to evolutionary
pressure, functional B. bovis homologs of T. parva and P.
falciparum proteins may have diverged in sequence to the
point they are no longer recognizable at the level of the
primary amino acid sequence. For this reason, we examined
the conservation of gene order in syntenic blocks between the
pathogens. Syntenic blocks were deﬁned as a pair of genes
that belong to the same Jf-COG, where members of the pair
belong to the reference and query sequence [10]. Even by this
method, we were unable to identify obvious homologs for
many P. falciparum proteins involved in stage-speciﬁc biology
or host immunity. However, in T. parva, the regions ﬂanking a
gene encoding an abundant sporozoite surface antigen, p67, a
primary target of parasite neutralizing antibodies [72], form a
highly conserved syntenic block with B. bovis and T. annulata
(Figure S6). Sporozoite antigen 1 (SPAG-1), the positional
homolog of p67 in T. annulata, is itself known to contain
neutralizing epitopes and is a leading vaccine candidate [73].
The gene in B. bovis (BBOV_IV007750) that occupies the site
of p67 in T. parva is predicted to encode a membrane protein,
suggesting that this protein may have immunostimulatory
properties equivalent to p67. RT-PCR experiments indicate
that the B. bovis gene is transcribed in infected erythrocytes
and during the kinete stage in ticks (unpublished data;
sporozoite expression has not been examined). It will be
interesting to explore the vaccine potential of the B. bovis p67
homolog, as ;50% of cattle immunized with recombinant
p67 and challenged under ﬁeld conditions show a reduction
in severe East Coast fever [74].
Large blocks of synteny are evident between B. bovis and T.
parva chromosomes (Figure 4A). However, several chromoso-
mal rearrangements have taken place, as observed between
chromosomes of P. falciparum and P. yoelii yoelii [75]. Synteny
rarely extends to telomeres (Figure 4B), as these regions
usually contain species-speciﬁc polymorphic genes that are
present at many syntenic break points. Unlike the T. parva
subtelomeric regions, the B. bovis subtelomeres contain genes
transcribed from both strands. However, similar to both T.
parva and P. falciparum, the telomeres contain many (putative)
membrane proteins. At a gross level, B. bovis chromosomes 2
and 4 primarily consist of sections of T. parva chromosome 4
and 2, and 3 and 1, respectively. B. bovis chromosome 3
contains sections from all four T. parva chromosomes, while
B. bovis chromosome 1 contains DNA from T. parva
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syntenic blocks indicates that inversions in gene order have
also taken place.
Summary
The 8.2 Mbp genome of B. bovis consists of four nuclear
chromosomes, and two small extra-nuclear chromosomes for
the apicoplast and mitochondria. B. bovis appears to have one
of the smallest apicomplexan genomes sequenced to date.
Consistent with the small genome size, analysis of enzyme
pathways reveals a reduced metabolic potential, and provides
a better understanding of B. bovis metabolism and potential
avenues for drug therapies. Using several different ap-
proaches, identiﬁcation of proteins predicted to be targeted
to the apicoplast reveals far fewer proteins than for related
organisms. This may be due in part to the lack of appropriate
detection algorithms. However, the conservative approach
used to identify the genes encoding these proteins provides a
solid base from which to extend these analyses. A foundation
for the elucidation of antigenic variation and immune
evasion has been established with genome-wide character-
Figure 4. Diagram of Chromosomal Synteny between B. bovis and T. parva
(A) Synteny at the chromosomal level. B. bovis chromosome number is indicated at the top. Bars on the right side of each chromosome diagram
designate B. bovis genes, with black bars indicating B. bovis ves1 genes and gray bars indicating other genes. The colors on the left of each chromosome
diagram indicate to which T. parva chromosome an ortholog belongs as follows: Tp1 ¼ red, Tp2 ¼ green, Tp3 ¼ blue, Tp4 ¼ orange.
(B) Comparison of telomeric arrangement of genes for B. bovis and T. parva chromosome 2. The gray line indicates the chromosomal backbone, with
black dots indicating the telomere. Large genes are depicted as arrows with coding direction indicated, while small genes have an arrowhead beneath
the gene to indicate the direction of transcription. Gray double arrowheads indicate that the chromosome continues. Colors indicate gene content as
follows: blue¼B. bovis ves1a, red¼B. bovis ves1b, yellow¼B. bovis SmORF, pale green¼putative membrane protein, pale blue¼annotated genes with
predicted function, black ¼ hypothetical, orange ¼ T. parva family 3 hypothetical, purple ¼ T. parva family 1 hypothetical, green ¼ ABC transporter.
doi:10.1371/journal.ppat.0030148.g004
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smorf gene family. ves1 and smorf genes are co-distributed
throughout the chromosome, with the majority located away
from telomeres and centromeres. As many as 33 potential loci
of ves1 transcription have been identiﬁed, and cDNA analysis
suggests that this transcription is more broad-based than with
other hemoprotozoa. Comparative analysis indicates that
many stage-speciﬁc and immunologically important genes
from P. falciparum are absent in B. bovis. However, through
both COG analysis and synteny, additional B. bovis vaccine
candidates, including homologs of P. falciparum p36, Pf12, T.
parva p67, and four of six T. parva proteins targeted by CD8
þ
cytotoxic T cells, have been identiﬁed.
Methods
Parasite culture and library construction. R. microplus adults were
allowed to feed on calf C-912 inoculated with the T2Bo strain that
was one passage (splenectomized calf) removed from a ﬁeld isolate
and frozen as a liquid nitrogen stabilate [76]. Progeny larvae were
placed on calf C-936, blood was collected 7 d post tick infestation,
and microaerophilous stationary phase culture was established
according to [77] with modiﬁcations as described in [18]. Parasite
genomic DNA from parasites in culture for 34–39 weeks was
extracted using standard methods [78]. Small (2–3 kbp) and medium
(12–15 kbp) insert libraries were constructed by nebulization and
cloning into pHOS2. A large insert library (100–145 kbp) was
constructed in pECBAC1 (Amplicon Express) and consisted of clones
resulting from HindIII or MboI partially digested DNA.
Genome sequencing. A total of 103,478 high quality sequence reads
(average read length ¼ 870) were generated (58,251 reads from the
small insert library and 45,227 reads from the medium insert library)
and assembled using Celera Assembler (http://sourceforge.net/
projects/wgs-assembler/). The sequence data fell into 50 scaffolds
consisting of 88 contigs. The bacterial artiﬁcial chromosome library
was end sequenced to generate an additional 2,874 reads that were
used to conﬁrm the assembly and for targeted sequencing in the
closure phase. Gaps in the assembly were closed by a combination of
primer walking and transposon based or shotgun sequencing of
medium insert clones, bacterial artiﬁcial chromosome clones, or PCR
products. This genome project has been deposited at DDBJ/EMBL/
GenBank under accession number AAXT00000000. The version
described in this paper is the ﬁrst version, AAXT01000000.
Functional annotation. Chromosomal gene models were predicted
using Phat [79], GlimmerHMM, TigrScan [80], and Unveil [81] after
training each gene ﬁnding algorithm on 499 partial and full-length B.
bovis genes totaling ;453 kbp. The training data were manually
constructed after inspection of the alignment of highly conserved
protein sequences from nraa using the AAT package [82] and PASA
to align a collection of ;11,000 B. bovis ESTs [17] to the genome
sequence. Jigsaw was used to derive consensus gene models [83] from
the outputs of the gene ﬁnding programs and protein alignments.
The consensus gene models were visually inspected and obvious
errors such as split or chimeric gene models were corrected based on
either EST or protein alignment evidence using the Neomorphic
Annotation Station [84] before promotion to working gene models.
Genes encoding tRNAs were identiﬁed using tRNAscan-SE [85].
BLAST [86] was used to search nraa using the predicted B. bovis
protein sequences, and protein domains were assigned using the
InterPro database [87]. The presence of secretory signals and
transmembrane domains were detected using SignalP [88] and
TMHMM [49], respectively. Functional gene assignments were
assigned based on the BLAST data, and a Web-based tool called
Manatee (http://manatee.sourceforge.net/) was used to manually
curate and annotate the data. Proteins were annotated as hypo-
thetical proteins if there was less than 35% sequence identity to
known proteins, and as conserved hypothetical proteins if there was
greater than 35% sequence identity to other proteins in the database
that were unnamed. If a protein was predicted to have a signal
peptide and at least one transmembrane domain, but was otherwise
considered as a hypothetical or conserved hypothetical protein, it
was annotated as a membrane protein, putative. If there was greater
than 35% sequence identity for 70% of the sequence length, the
protein product would be assigned a name only when a publication
record could verify the authenticity of the named product. In the
absence of published evidence, the named product was listed as
putative. The mitochondrial and apicoplast genomes were manually
annotated, and apicoplast-targeted proteins were analyzed using
PlasmoAP (http://v4-4.plasmodb.org/restricted/PlasmoAPcgi.shtml)
[31]. PASA [89] was used to align ;86% of the B. bovis ESTs to the
genome sequence data and provided evidence for transcription of
1,633 genes.
Comparative analyses. Sybil (http://sybil.sourceforge.net/) was used
to create an all-versus-all BLASTP search using the proteomes of B.
bovis, T. parva, and P. falciparum. These outputs were subjected to
Jaccard clustering [10], placing proteins into distinct clusters for each
proteome. Clusters from different proteomes were linked based on
best bidirectional BLASTP hits between them to provide Jf-COGs. A
minimum block size of ﬁve with one gap was allowed in the analyses.
cDNA analyses. Analysis of ves1 transcription utilized total RNA
isolated from microaerophilous stationary phase culture culture
using TRIzol (BRL) treated three times with RNase-free DNase
(Ambion) for 30 min at 37 8C. RNA was reverse transcribed with a
Superscript (Invitrogen) reverse transcription kit using random
hexamers according to the manufacturer’s instructions. Universal
primer sequences that would anneal to the two speciﬁc subunit types
could not be found. Therefore, in the ﬁrst RT-PCR experiment,
primers were designed to amplify as many of the genes as possible.
The following primers were used for ves1b cDNA: beta2For: 59 GGA
CTA CAG AAG TGG GTT GGG TGG and beta4Rev: 59 ATA GCC
CAT GGC CGC CAT GAA TGA; ves1a cDNA: alpha3For: 59 CAG GTA
CTC AGT GCA CTC GTT GGG TGG AG and alpha6Rev: 59 CCC TAA
TGT AGT GNA CCA CCT GGT TGT ATG C. Due to the high degree
of sequence similarity (.99%) of the published ves1 loci in cosmid 53
and 54 (accession numbers AY279553 and AY279554, respectively) to
the genome sequence, a second RT-PCR experiment used primers
designed to amplify the published LAT [37]. This experiment used
primers LATbetaF1: 59 GCA ACC GCA CGA CAG and LATbetaR2: 59
CGC TGA CAC GCT AGT for the ves1b gene. A ﬁnal cDNA cloning
experiment was designed to elucidate the transcriptional proﬁle for
ves1 by targeting ves1a and ves1b genes associated with Rep sequence
clusters [37]. Primers were as follows: ves1b: 00789F1: 59 AGA CTG
TGA ATC TCG GCT CA and 00789R: 59 CAG CGG CAC CAC TAC
CTT T; ves1a: 00792F2: 59 TGC CCA GGA CAG TTA TG and
00792R2: 59 TGA TGC CCT CTT CAA TAG TT. Whenever possible,
ves1 primers were designed such that they would ﬂank introns,
providing an additional assurance that the amplicon obtained was
not from contaminating genomic DNA; however, this was only
possible for ves1b experiments.
Supporting Information
Figure S1. Diagram of B. bovis Apicoplast Genome
Coding sequences (CDSs) with functional annotation are depicted in
red, while hypothetical CDSs are shown in lack. Genes encoding
tRNA genes are shown as blue bars, while rRNA genes are shown as
yellow arrows. All genes are unidirectionally encoded.
Found at doi:10.1371/journal.ppat.0030148.sg001 (303 KB PDF).
Figure S2. Diagram of B. bovis Mitochondrial Genome
CDSs are depicted in red, large subunit rRNA genes in blue, and
inverted terminal repeats as black arrows.
Found at doi:10.1371/journal.ppat.0030148.sg002 (38 KB PDF).
Figure S3. Diagram of the 24 Putative ves1 LAT Loci
All loci are depicted with ves1b on the left and ves1a on the right and
drawn to the same scale. The genome backbone is a yellow line, exons
are orange, and introns are shown as blank boxes. The systematic
gene name for each gene is shown. Transmembrane helices
(TMHelix), coiled-coil domains (Coiled Coil), and the variant domains
with conserved sequences 1 and 2 (VDCS-1 or  2) are indicated.
Found at doi:10.1371/journal.ppat.0030148.sg003 (327 KB PDF).
Figure S4. Alignment of 44 SmORF Sequences
Deduced amino acid sequences were aligned with the AlignX module
of VectoNTI. The blue background indicates positions with identical
amino acid sequences, while the green background indicates
conserved amino acids. Dashes indicate that there is no amino acid
in that position. Long stretches of intervening amino acid sequence
has been trimmed from a few sequences to allow visualization of the
four blocks of amino acid conservation. The double slashes (//)
indicate that the sequence was trimmed from this position that
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single slash (/) indicates that the sequence that was trimmed from the
alignment that did not fully span the region was removed. The total
alignment length is 720 amino acids in length.
Found at doi:10.1371/journal.ppat.0030148.sg004 (43 KB PDF).
Figure S5. Venn Diagram Showing Number of Genes in Overlapping
COGs between B. bovis, T. parva, and P. falciparum
Found at doi:10.1371/journal.ppat.0030148.sg005 (14 KB PDF).
Figure S6. Example of Microsynteny between B. bovis and T. parva
The T. parva p67 locus is diagrammed in the middle row, with the
corresponding B. bovis locus shown on the top row, and the T. annulata
SPAG-1 locus diagrammed on the bottom row. Genes with sequence
identity between species are connected by shaded gray lines. The
gene highlighted with pink was used to identify the syntenic locus.
The p67 gene is indicated.
Found at doi:10.1371/journal.ppat.0030148.sg006 (52 KB PDF).
Table S1. Transporters
Found at doi:10.1371/journal.ppat.0030148.st001 (85 KB DOC).
Table S2. Characteristics of Apicomplexan Plastids
Found at doi:10.1371/journal.ppat.0030148.st002 (34 KB DOC).
Table S3. Nuclear Encoded Genes Potentially Targeted to the
Apicoplast
Found at doi:10.1371/journal.ppat.0030148.st003 (104 KB DOC).
Table S4. Characteristics of ves1 Sequences
Found at doi:10.1371/journal.ppat.0030148.st004 (44 KB XLS).
Table S5. CDS common to B. bovis, T. parva, and P. falciparum
Found at doi:10.1371/journal.ppat.0030148.st005 (728 KB XLS).
Table S6. CDS Unique to B. bovis
Found at doi:10.1371/journal.ppat.0030148.st006 (97 KB XLS).
Table S7. CDS Unique to T. parva
Found at doi:10.1371/journal.ppat.0030148.st007 (138 KB XLS).
Table S8. CDS Unique to P. falciparum
Found at doi:10.1371/journal.ppat.0030148.st008 (388 KB XLS).
Accession Number
The B. bovis T2Bo genome is deposited at DDBJ/EMBL/GenBank
under accession number AAXT00000000.
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